Alberto Rocci

Medicine · Health Sciences

25h-index2.8kcitations96works1.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(55), Protein Degradation and Inhibitors(15), Telomeres, Telomerase, and Senescence(13), Acute Myeloid Leukemia Research(12), MicroRNA in disease regulation(10)

Publications96 total

P-389 Phase 3, Two-stage, Randomized Trials of Mezigdomide-Based Regimens Versus Standard Regimens in Relapsed/Refractory Multiple Myeloma (RRMM): SUCCESSOR-1 (MeziVd vs PVd) and SUCCESSOR-2 (MeziKd vs Kd)
Clinical Lymphoma Myeloma & Leukemia·2024· 1 cited
POSTER: MM-372 A Phase III, Two-Stage, Randomized Study of Mezigdomide, Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Relapsed/Refractory Multiple Myeloma (RRMM): SUCCESSOR-1
Clinical Lymphoma Myeloma & Leukemia·2023· 2 cited
MM-372 A Phase III, Two-Stage, Randomized Study of Mezigdomide, Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Relapsed/Refractory Multiple Myeloma (RRMM): SUCCESSOR-1
Clinical Lymphoma Myeloma & Leukemia·2023· 6 cited
A phase 3, two-stage, randomized study of mezigdomide, carfilzomib, and dexamethasone (MeziKd) versus carfilzomib and dexamethasone (Kd) in relapsed/refractory multiple myeloma (RRMM): SUCCESSOR-2.
Journal of Clinical Oncology·2023· 6 cited
RWD-derived response in multiple myeloma
PLoS ONE·2023· 4 citedOpen Access
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
Cancer Cell·2022· 2 citedOpen Access
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
Cancer Cell·2022Open Access
Lab-Based Response Assessment Algorithm Recapitulates Investigator's Response Assessment in the Phase 3 Bellini Trial
Blood·2021
Assessment of Associations between Derived Response and Overall Survival in Patients with Multiple Myeloma Using a US-Based Electronic Health Records Database
Blood·2021
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial
PLoS Medicine·2021· 35 citedOpen Access
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
Blood Cancer Journal·2020· 117 citedOpen Access
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages
JCI Insight·2019· 41 citedOpen Access
Evaluating Suspected Cardiac Amyloidosis
JACC Case Reports·2019Open Access
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation
JAMA·2019· 244 citedOpen Access
Minimal residual disease by flow cytometry and allelic‐specific oligonucleotide real‐time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
Cancer·2018· 38 citedOpen Access
Venous thromboembolism in multiple myeloma – choice of prophylaxis, role of direct oral anticoagulants and special considerations
British Journal of Haematology·2018· 65 citedOpen Access
Treatment algorithm for multiple myeloma: Real-world insights across five European countries
Annals of Oncology·2018Open Access
Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
Leukemia·2017· 90 cited
TOURMALINE-MM1: new oral triplet combination for patients with relapsed/refractory multiple myeloma
Translational Cancer Research·2017
TOURMALINE-MM1: new oral triplet combination for patients with relapsed/refractory multiple myeloma
Translational Cancer Research·2017Open Access
page 1 of 5Next →

Frequent Co-authors

Antonio Palumbo(21), Mario Boccadoro(21), Marco Ladetto(14), Daniela Drandi(12), Paola Omedè(10), Irene Ricca(9), Craig C. Hofmeister(8), Corrado Tarella(8), Manuela Gambella(8), Monica Astolfi(7), Flavia Pichiorri(6), Luciana De Luca(6), Luigia Monitillo(6), Roberto Passera(6), Sonia Vallet(6), Federica Cavallo(6), Roberto Francese(6), Mara Compagno(6), Stefano Volinia(5), Carlo M. Croce(5)